245 related articles for article (PubMed ID: 19428118)
21. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
22. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
[TBL] [Abstract][Full Text] [Related]
23. Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
Edinger JD; Manber R; Buysse DJ; Krystal AD; Thase ME; Gehrman P; Fairholme CP; Luther J; Wisniewski S
J Clin Sleep Med; 2017 Feb; 13(2):205-213. PubMed ID: 27784414
[TBL] [Abstract][Full Text] [Related]
24. Treatment response in type 2 diabetes patients with major depression.
Gois C; Dias VV; Carmo I; Duarte R; Ferro A; Santos AL; Sousa F; Barbosa A
Clin Psychol Psychother; 2014; 21(1):39-48. PubMed ID: 22962030
[TBL] [Abstract][Full Text] [Related]
25. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.
Hegerl U; Hautzinger M; Mergl R; Kohnen R; Schütze M; Scheunemann W; Allgaier AK; Coyne J; Henkel V
Int J Neuropsychopharmacol; 2010 Feb; 13(1):31-44. PubMed ID: 19341510
[TBL] [Abstract][Full Text] [Related]
26. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
[TBL] [Abstract][Full Text] [Related]
27. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
Szegedi A; Jansen WT; van Willigenburg AP; van der Meulen E; Stassen HH; Thase ME
J Clin Psychiatry; 2009 Mar; 70(3):344-53. PubMed ID: 19254516
[TBL] [Abstract][Full Text] [Related]
28. Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
Cowan MJ; Freedland KE; Burg MM; Saab PG; Youngblood ME; Cornell CE; Powell LH; Czajkowski SM;
Psychother Psychosom; 2008; 77(1):27-37. PubMed ID: 18087205
[TBL] [Abstract][Full Text] [Related]
29. Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.
Henkel V; Mergl R; Allgaier AK; Hautzinger M; Kohnen R; Coyne JC; Möller HJ; Hegerl U
Eur Psychiatry; 2010 Dec; 25(8):491-8. PubMed ID: 20965118
[TBL] [Abstract][Full Text] [Related]
30. Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Zahn D; Müller MJ
Diabetes Care; 2015 May; 38(5):767-75. PubMed ID: 25690005
[TBL] [Abstract][Full Text] [Related]
31. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
32. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
33. Exercise and pharmacotherapy in the treatment of major depressive disorder.
Blumenthal JA; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; Barbour KA; Herman S; Craighead WE; Brosse AL; Waugh R; Hinderliter A; Sherwood A
Psychosom Med; 2007; 69(7):587-96. PubMed ID: 17846259
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
35. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
[TBL] [Abstract][Full Text] [Related]
36. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
[TBL] [Abstract][Full Text] [Related]
37. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
[TBL] [Abstract][Full Text] [Related]
38. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
Cao Y; Li W; Shen J; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
[TBL] [Abstract][Full Text] [Related]
39. Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
Hedayati SS; Daniel DM; Cohen S; Comstock B; Cukor D; Diaz-Linhart Y; Dember LM; Dubovsky A; Greene T; Grote N; Heagerty P; Katon W; Kimmel PL; Kutner N; Linke L; Quinn D; Rue T; Trivedi MH; Unruh M; Weisbord S; Young BA; Mehrotra R
Contemp Clin Trials; 2016 Mar; 47():1-11. PubMed ID: 26621218
[TBL] [Abstract][Full Text] [Related]
40. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
Binneman B; Feltner D; Kolluri S; Shi Y; Qiu R; Stiger T
Am J Psychiatry; 2008 May; 165(5):617-20. PubMed ID: 18413705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
